| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 52 |
| 1 | ASPIRIN 325 MG | 52 |
| 2 | ASPIRIN 81 MG | 52 |
| 3 | METHYLDOPA | 46 |
| 4 | METOPROLOL | 41 |
| 5 | METOPROLOL TARTRATE | 41 |
| 6 | METOPROLOL TARTRATE INJECTION | 38 |
| 7 | NIFEDIPINE | 36 |
| 8 | PREDNISONE | 30 |
| 9 | VENLAFAXINE HYDROCHLORIDE | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAGULATION FACTOR XIII A-SUBUNIT (RECOMBINANT) | 1 | 0.0714 |
| 1 | PRENATAL SUPPLEMENT WITH DHA | 1 | 0.0227 |
| 2 | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | 1 | 0.0164 |
| 3 | METHYLDOPA | 46 | 0.0093 |
| 4 | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | 1 | 0.0068 |
| 5 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 6 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 7 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2 | 0.0041 |
| 8 | OXYTOCIN | 9 | 0.0030 |
| 9 | NARATRIPTAN | 4 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 75 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 52 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 46 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 39 |
| 5 | Purine Antimetabolite [EPC] | 27 |
| 6 | Vitamin C [EPC] | 27 |
| 7 | Vitamin B12 [EPC] | 24 |
| 8 | Vitamin D [EPC] | 24 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 9 | 0.0030 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 2 | Progesterone [EPC] | 17 | 0.0007 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 4 | Sulfonamide Antibacterial [EPC] | 2 | 0.0005 |
| 5 | Protease Inhibitor [EPC] | 22 | 0.0005 |
| 6 | Prostaglandin E1 Analog [EPC] | 8 | 0.0005 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0005 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 22 | 0.0004 |
| 9 | Human Immunoglobulin G [EPC] | 7 | 0.0003 |